TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global In Vitro ADME-Tox Market Insights, Forecast to 2028

Global In Vitro ADME-Tox Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 03 August 2022
  • Pages :116
  • Formats:
  • Report Code:SMR-7252026
OfferClick for best price

Best Price: $3920

In Vitro ADMETox Market Size, Share 2022


Market Analysis and Insights: Global In Vitro ADMETox Market

The global In Vitro ADMETox market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In Vitro ADMETox market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In Vitro ADMETox market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In Vitro ADMETox market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In Vitro ADMETox market.

Global In Vitro ADMETox Scope and Market Size

In Vitro ADME-Tox market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global In Vitro ADME-Tox market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Segment by Application

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others

By Company

  • Charles River
  • Labcorp
  • Envigo
  • Curia
  • Evotec
  • Bioduro-Sundia
  • Lonza
  • WuXi AppTec
  • IQVIA
  • Tecan Group
  • Pharmaron
  • Shanghai Medicilon
  • ChemPartner
  • Joinn Laboratories
  • RTI International
  • Eurofins Scientific
  • Aragen Life Sciences
  • Sai Life Sciences

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes In Vitro ADMETox product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of In Vitro ADMETox, with price, sales, revenue, and global market share of In Vitro ADMETox from 2019 to 2022.

Chapter 3, the In Vitro ADMETox competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the In Vitro ADMETox breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the In Vitro ADMETox market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of In Vitro ADMETox.

Chapter 13, 14, and 15, to describe In Vitro ADMETox sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 In Vitro ADMETox Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global In Vitro ADME-Tox Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 116 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro ADME-Tox Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vitro ADME-Tox Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vitro ADME-Tox Market Perspective (2017-2028)
2.2 In Vitro ADME-Tox Growth Trends by Region
2.2.1 In Vitro ADME-Tox Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In Vitro ADME-Tox Historic Market Size by Region (2017-2022)
2.2.3 In Vitro ADME-Tox Forecasted Market Size by Region (2023-2028)
2.3 In Vitro ADME-Tox Market Dynamics
2.3.1 In Vitro ADME-Tox Industry Trends
2.3.2 In Vitro ADME-Tox Market Drivers
2.3.3 In Vitro ADME-Tox Market Challenges
2.3.4 In Vitro ADME-Tox Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro ADME-Tox Players by Revenue
3.1.1 Global Top In Vitro ADME-Tox Players by Revenue (2017-2022)
3.1.2 Global In Vitro ADME-Tox Revenue Market Share by Players (2017-2022)
3.2 Global In Vitro ADME-Tox Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro ADME-Tox Revenue
3.4 Global In Vitro ADME-Tox Market Concentration Ratio
3.4.1 Global In Vitro ADME-Tox Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro ADME-Tox Revenue in 2021
3.5 In Vitro ADME-Tox Key Players Head office and Area Served
3.6 Key Players In Vitro ADME-Tox Product Solution and Service
3.7 Date of Enter into In Vitro ADME-Tox Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro ADME-Tox Breakdown Data by Type
4.1 Global In Vitro ADME-Tox Historic Market Size by Type (2017-2022)
4.2 Global In Vitro ADME-Tox Forecasted Market Size by Type (2023-2028)
5 In Vitro ADME-Tox Breakdown Data by Application
5.1 Global In Vitro ADME-Tox Historic Market Size by Application (2017-2022)
5.2 Global In Vitro ADME-Tox Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Vitro ADME-Tox Market Size (2017-2028)
6.2 North America In Vitro ADME-Tox Market Size by Type
6.2.1 North America In Vitro ADME-Tox Market Size by Type (2017-2022)
6.2.2 North America In Vitro ADME-Tox Market Size by Type (2023-2028)
6.2.3 North America In Vitro ADME-Tox Market Share by Type (2017-2028)
6.3 North America In Vitro ADME-Tox Market Size by Application
6.3.1 North America In Vitro ADME-Tox Market Size by Application (2017-2022)
6.3.2 North America In Vitro ADME-Tox Market Size by Application (2023-2028)
6.3.3 North America In Vitro ADME-Tox Market Share by Application (2017-2028)
6.4 North America In Vitro ADME-Tox Market Size by Country
6.4.1 North America In Vitro ADME-Tox Market Size by Country (2017-2022)
6.4.2 North America In Vitro ADME-Tox Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In Vitro ADME-Tox Market Size (2017-2028)
7.2 Europe In Vitro ADME-Tox Market Size by Type
7.2.1 Europe In Vitro ADME-Tox Market Size by Type (2017-2022)
7.2.2 Europe In Vitro ADME-Tox Market Size by Type (2023-2028)
7.2.3 Europe In Vitro ADME-Tox Market Share by Type (2017-2028)
7.3 Europe In Vitro ADME-Tox Market Size by Application
7.3.1 Europe In Vitro ADME-Tox Market Size by Application (2017-2022)
7.3.2 Europe In Vitro ADME-Tox Market Size by Application (2023-2028)
7.3.3 Europe In Vitro ADME-Tox Market Share by Application (2017-2028)
7.4 Europe In Vitro ADME-Tox Market Size by Country
7.4.1 Europe In Vitro ADME-Tox Market Size by Country (2017-2022)
7.4.2 Europe In Vitro ADME-Tox Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro ADME-Tox Market Size (2017-2028)
8.2 Asia-Pacific In Vitro ADME-Tox Market Size by Type
8.2.1 Asia-Pacific In Vitro ADME-Tox Market Size by Type (2017-2022)
8.2.2 Asia-Pacific In Vitro ADME-Tox Market Size by Type (2023-2028)
8.2.3 Asia-Pacific In Vitro ADME-Tox Market Share by Type (2017-2028)
8.3 Asia-Pacific In Vitro ADME-Tox Market Size by Application
8.3.1 Asia-Pacific In Vitro ADME-Tox Market Size by Application (2017-2022)
8.3.2 Asia-Pacific In Vitro ADME-Tox Market Size by Application (2023-2028)
8.3.3 Asia-Pacific In Vitro ADME-Tox Market Share by Application (2017-2028)
8.4 Asia-Pacific In Vitro ADME-Tox Market Size by Region
8.4.1 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2017-2022)
8.4.2 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In Vitro ADME-Tox Market Size (2017-2028)
9.2 Latin America In Vitro ADME-Tox Market Size by Type
9.2.1 Latin America In Vitro ADME-Tox Market Size by Type (2017-2022)
9.2.2 Latin America In Vitro ADME-Tox Market Size by Type (2023-2028)
9.2.3 Latin America In Vitro ADME-Tox Market Share by Type (2017-2028)
9.3 Latin America In Vitro ADME-Tox Market Size by Application
9.3.1 Latin America In Vitro ADME-Tox Market Size by Application (2017-2022)
9.3.2 Latin America In Vitro ADME-Tox Market Size by Application (2023-2028)
9.3.3 Latin America In Vitro ADME-Tox Market Share by Application (2017-2028)
9.4 Latin America In Vitro ADME-Tox Market Size by Country
9.4.1 Latin America In Vitro ADME-Tox Market Size by Country (2017-2022)
9.4.2 Latin America In Vitro ADME-Tox Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro ADME-Tox Market Size (2017-2028)
10.2 Middle East & Africa In Vitro ADME-Tox Market Size by Type
10.2.1 Middle East & Africa In Vitro ADME-Tox Market Size by Type (2017-2022)
10.2.2 Middle East & Africa In Vitro ADME-Tox Market Size by Type (2023-2028)
10.2.3 Middle East & Africa In Vitro ADME-Tox Market Share by Type (2017-2028)
10.3 Middle East & Africa In Vitro ADME-Tox Market Size by Application
10.3.1 Middle East & Africa In Vitro ADME-Tox Market Size by Application (2017-2022)
10.3.2 Middle East & Africa In Vitro ADME-Tox Market Size by Application (2023-2028)
10.3.3 Middle East & Africa In Vitro ADME-Tox Market Share by Application (2017-2028)
10.4 Middle East & Africa In Vitro ADME-Tox Market Size by Country
10.4.1 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2017-2022)
10.4.2 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vitro ADME-Tox Introduction
11.1.4 Charles River Revenue in In Vitro ADME-Tox Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vitro ADME-Tox Introduction
11.2.4 Labcorp Revenue in In Vitro ADME-Tox Business (2017-2022)
11.2.5 Labcorp Recent Developments
11.3 Envigo
11.3.1 Envigo Company Details
11.3.2 Envigo Business Overview
11.3.3 Envigo In Vitro ADME-Tox Introduction
11.3.4 Envigo Revenue in In Vitro ADME-Tox Business (2017-2022)
11.3.5 Envigo Recent Developments
11.4 Curia
11.4.1 Curia Company Details
11.4.2 Curia Business Overview
11.4.3 Curia In Vitro ADME-Tox Introduction
11.4.4 Curia Revenue in In Vitro ADME-Tox Business (2017-2022)
11.4.5 Curia Recent Developments
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec In Vitro ADME-Tox Introduction
11.5.4 Evotec Revenue in In Vitro ADME-Tox Business (2017-2022)
11.5.5 Evotec Recent Developments
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Details
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In Vitro ADME-Tox Introduction
11.6.4 Bioduro-Sundia Revenue in In Vitro ADME-Tox Business (2017-2022)
11.6.5 Bioduro-Sundia Recent Developments
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza In Vitro ADME-Tox Introduction
11.7.4 Lonza Revenue in In Vitro ADME-Tox Business (2017-2022)
11.7.5 Lonza Recent Developments
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In Vitro ADME-Tox Introduction
11.8.4 WuXi AppTec Revenue in In Vitro ADME-Tox Business (2017-2022)
11.8.5 WuXi AppTec Recent Developments
11.9 IQVIA
11.9.1 IQVIA Company Details
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In Vitro ADME-Tox Introduction
11.9.4 IQVIA Revenue in In Vitro ADME-Tox Business (2017-2022)
11.9.5 IQVIA Recent Developments
11.10 Tecan Group
11.10.1 Tecan Group Company Details
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In Vitro ADME-Tox Introduction
11.10.4 Tecan Group Revenue in In Vitro ADME-Tox Business (2017-2022)
11.10.5 Tecan Group Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In Vitro ADME-Tox Introduction
11.11.4 Pharmaron Revenue in In Vitro ADME-Tox Business (2017-2022)
11.11.5 Pharmaron Recent Developments
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Details
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In Vitro ADME-Tox Introduction
11.12.4 Shanghai Medicilon Revenue in In Vitro ADME-Tox Business (2017-2022)
11.12.5 Shanghai Medicilon Recent Developments
11.13 ChemPartner
11.13.1 ChemPartner Company Details
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In Vitro ADME-Tox Introduction
11.13.4 ChemPartner Revenue in In Vitro ADME-Tox Business (2017-2022)
11.13.5 ChemPartner Recent Developments
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Details
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In Vitro ADME-Tox Introduction
11.14.4 Joinn Laboratories Revenue in In Vitro ADME-Tox Business (2017-2022)
11.14.5 Joinn Laboratories Recent Developments
11.15 RTI International
11.15.1 RTI International Company Details
11.15.2 RTI International Business Overview
11.15.3 RTI International In Vitro ADME-Tox Introduction
11.15.4 RTI International Revenue in In Vitro ADME-Tox Business (2017-2022)
11.15.5 RTI International Recent Developments
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Details
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In Vitro ADME-Tox Introduction
11.16.4 Eurofins Scientific Revenue in In Vitro ADME-Tox Business (2017-2022)
11.16.5 Eurofins Scientific Recent Developments
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Details
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In Vitro ADME-Tox Introduction
11.17.4 Aragen Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022)
11.17.5 Aragen Life Sciences Recent Developments
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Details
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In Vitro ADME-Tox Introduction
11.18.4 Sai Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022)
11.18.5 Sai Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global In Vitro ADME-Tox Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global In Vitro ADME-Tox Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global In Vitro ADME-Tox Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global In Vitro ADME-Tox Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global In Vitro ADME-Tox Market Share by Region (2017-2022)
Table 8. Global In Vitro ADME-Tox Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global In Vitro ADME-Tox Market Share by Region (2023-2028)
Table 10. In Vitro ADME-Tox Market Trends
Table 11. In Vitro ADME-Tox Market Drivers
Table 12. In Vitro ADME-Tox Market Challenges
Table 13. In Vitro ADME-Tox Market Restraints
Table 14. Global In Vitro ADME-Tox Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global In Vitro ADME-Tox Revenue Share by Players (2017-2022)
Table 16. Global Top In Vitro ADME-Tox by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro ADME-Tox as of 2021)
Table 17. Ranking of Global Top In Vitro ADME-Tox Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by In Vitro ADME-Tox Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro ADME-Tox Product Solution and Service
Table 21. Date of Enter into In Vitro ADME-Tox Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global In Vitro ADME-Tox Revenue Market Share by Type (2017-2022)
Table 25. Global In Vitro ADME-Tox Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global In Vitro ADME-Tox Revenue Market Share by Type (2023-2028)
Table 27. Global In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global In Vitro ADME-Tox Revenue Share by Application (2017-2022)
Table 29. Global In Vitro ADME-Tox Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global In Vitro ADME-Tox Revenue Share by Application (2023-2028)
Table 31. North America In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America In Vitro ADME-Tox Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America In Vitro ADME-Tox Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America In Vitro ADME-Tox Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America In Vitro ADME-Tox Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe In Vitro ADME-Tox Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe In Vitro ADME-Tox Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe In Vitro ADME-Tox Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe In Vitro ADME-Tox Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific In Vitro ADME-Tox Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific In Vitro ADME-Tox Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific In Vitro ADME-Tox Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific In Vitro ADME-Tox Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America In Vitro ADME-Tox Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America In Vitro ADME-Tox Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America In Vitro ADME-Tox Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America In Vitro ADME-Tox Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa In Vitro ADME-Tox Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa In Vitro ADME-Tox Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa In Vitro ADME-Tox Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa In Vitro ADME-Tox Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa In Vitro ADME-Tox Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa In Vitro ADME-Tox Market Size by Country (2023-2028) & (US$ Million)
Table 61. Charles River Company Details
Table 62. Charles River Business Overview
Table 63. Charles River In Vitro ADME-Tox Product
Table 64. Charles River Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 65. Charles River Recent Developments
Table 66. Labcorp Company Details
Table 67. Labcorp Business Overview
Table 68. Labcorp In Vitro ADME-Tox Product
Table 69. Labcorp Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 70. Labcorp Recent Developments
Table 71. Envigo Company Details
Table 72. Envigo Business Overview
Table 73. Envigo In Vitro ADME-Tox Product
Table 74. Envigo Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 75. Envigo Recent Developments
Table 76. Curia Company Details
Table 77. Curia Business Overview
Table 78. Curia In Vitro ADME-Tox Product
Table 79. Curia Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 80. Curia Recent Developments
Table 81. Evotec Company Details
Table 82. Evotec Business Overview
Table 83. Evotec In Vitro ADME-Tox Product
Table 84. Evotec Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 85. Evotec Recent Developments
Table 86. Bioduro-Sundia Company Details
Table 87. Bioduro-Sundia Business Overview
Table 88. Bioduro-Sundia In Vitro ADME-Tox Product
Table 89. Bioduro-Sundia Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 90. Bioduro-Sundia Recent Developments
Table 91. Lonza Company Details
Table 92. Lonza Business Overview
Table 93. Lonza In Vitro ADME-Tox Product
Table 94. Lonza Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 95. Lonza Recent Developments
Table 96. WuXi AppTec Company Details
Table 97. WuXi AppTec Business Overview
Table 98. WuXi AppTec In Vitro ADME-Tox Product
Table 99. WuXi AppTec Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 100. WuXi AppTec Recent Developments
Table 101. IQVIA Company Details
Table 102. IQVIA Business Overview
Table 103. IQVIA In Vitro ADME-Tox Product
Table 104. IQVIA Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 105. IQVIA Recent Developments
Table 106. Tecan Group Company Details
Table 107. Tecan Group Business Overview
Table 108. Tecan Group In Vitro ADME-Tox Product
Table 109. Tecan Group Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 110. Tecan Group Recent Developments
Table 111. Pharmaron Company Details
Table 112. Pharmaron Business Overview
Table 113. Pharmaron In Vitro ADME-Tox Product
Table 114. Pharmaron Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 115. Pharmaron Recent Developments
Table 116. Shanghai Medicilon Company Details
Table 117. Shanghai Medicilon Business Overview
Table 118. Shanghai Medicilon In Vitro ADME-Tox Product
Table 119. Shanghai Medicilon Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 120. Shanghai Medicilon Recent Developments
Table 121. ChemPartner Company Details
Table 122. ChemPartner Business Overview
Table 123. ChemPartner In Vitro ADME-Tox Product
Table 124. ChemPartner Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 125. ChemPartner Recent Developments
Table 126. Joinn Laboratories Company Details
Table 127. Joinn Laboratories Business Overview
Table 128. Joinn Laboratories In Vitro ADME-Tox Product
Table 129. Joinn Laboratories Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 130. Joinn Laboratories Recent Developments
Table 131. RTI International Company Details
Table 132. RTI International Business Overview
Table 133. RTI International In Vitro ADME-Tox Product
Table 134. RTI International Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 135. RTI International Recent Developments
Table 136. Eurofins Scientific Company Details
Table 137. Eurofins Scientific Business Overview
Table 138. Eurofins Scientific In Vitro ADME-Tox Product
Table 139. Eurofins Scientific Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 140. Eurofins Scientific Recent Developments
Table 141. Aragen Life Sciences Company Details
Table 142. Aragen Life Sciences Business Overview
Table 143. Aragen Life Sciences In Vitro ADME-Tox Product
Table 144. Aragen Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 145. Aragen Life Sciences Recent Developments
Table 146. Sai Life Sciences Company Details
Table 147. Sai Life Sciences Business Overview
Table 148. Sai Life Sciences In Vitro ADME-Tox Product
Table 149. Sai Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022) & (US$ Million)
Table 150. Sai Life Sciences Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro ADME-Tox Market Share by Type: 2021 VS 2028
Figure 2. Small Molecules Features
Figure 3. Biologics Features
Figure 4. Global In Vitro ADME-Tox Market Share by Application: 2021 VS 2028
Figure 5. Biopharmaceutical Companies Case Studies
Figure 6. Government and Academic Institutes Case Studies
Figure 7. Others Case Studies
Figure 8. In Vitro ADME-Tox Report Years Considered
Figure 9. Global In Vitro ADME-Tox Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global In Vitro ADME-Tox Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global In Vitro ADME-Tox Market Share by Region: 2021 VS 2028
Figure 12. Global In Vitro ADME-Tox Market Share by Players in 2021
Figure 13. Global Top In Vitro ADME-Tox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro ADME-Tox as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by In Vitro ADME-Tox Revenue in 2021
Figure 15. North America In Vitro ADME-Tox Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America In Vitro ADME-Tox Market Size Market Share by Type (2017-2028)
Figure 17. North America In Vitro ADME-Tox Market Size Market Share by Application (2017-2028)
Figure 18. North America In Vitro ADME-Tox Market Size Share by Country (2017-2028)
Figure 19. United States In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe In Vitro ADME-Tox Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe In Vitro ADME-Tox Market Size Market Share by Type (2017-2028)
Figure 23. Europe In Vitro ADME-Tox Market Size Market Share by Application (2017-2028)
Figure 24. Europe In Vitro ADME-Tox Market Size Share by Country (2017-2028)
Figure 25. Germany In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific In Vitro ADME-Tox Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific In Vitro ADME-Tox Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific In Vitro ADME-Tox Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific In Vitro ADME-Tox Market Size Share by Region (2017-2028)
Figure 35. China In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America In Vitro ADME-Tox Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America In Vitro ADME-Tox Market Size Market Share by Type (2017-2028)
Figure 43. Latin America In Vitro ADME-Tox Market Size Market Share by Application (2017-2028)
Figure 44. Latin America In Vitro ADME-Tox Market Size Share by Country (2017-2028)
Figure 45. Mexico In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa In Vitro ADME-Tox Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa In Vitro ADME-Tox Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa In Vitro ADME-Tox Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa In Vitro ADME-Tox Market Size Share by Country (2017-2028)
Figure 51. Turkey In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE In Vitro ADME-Tox Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Charles River Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 55. Labcorp Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 56. Envigo Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 57. Curia Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 58. Evotec Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 59. Bioduro-Sundia Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 60. Lonza Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 61. WuXi AppTec Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 62. IQVIA Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 63. Tecan Group Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 64. Pharmaron Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 65. Shanghai Medicilon Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 66. ChemPartner Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 67. Joinn Laboratories Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 68. RTI International Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 69. Eurofins Scientific Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 70. Aragen Life Sciences Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 71. Sai Life Sciences Revenue Growth Rate in In Vitro ADME-Tox Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount